Medicure (MCUJF) Income towards Parent Company (2009 - 2026)
Medicure's (MCUJF) quarterly Income towards Parent Company came in at -$296057.5 in Q1 2026, down 168.74% year-on-year from $430694.4 in Q1 2025, and up 95.72% quarter-over-quarter from -$6.9 million in Q4 2025.
Medicure (MCUJF) Income towards Parent Company (2009 - 2026) Analysis & Trends
Medicure's Income towards Parent Company history runs 18 years deep, the most recent figure standing at -$296057.5 for Q1 2026.
- On a quarterly basis, Income towards Parent Company fell 168.74% year-over-year to -$296057.5 in Q1 2026; TTM through Mar 2026 was -$8.8 million, a 2368.83% decrease from a year earlier, with the FY2025 full-year figure at -$5.1 million, down 569.33% from the prior year.
- Income towards Parent Company climbed to -$296057.5 in Q1 2026 per MCUJF's latest filing, from -$6.9 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $4.0 million in Q4 2022 and bottomed at -$6.9 million in Q4 2025.
- The 5-year median for Income towards Parent Company is $62658.2 (2023), against an average of -$182150.6.
- Biggest YoY gain for Income towards Parent Company was 1037.96% in 2025; the steepest drop was 1648.95% in 2025.
- Year by year, Income towards Parent Company stood at $4.0 million in 2022, then tumbled by 128.63% to -$1.1 million in 2023, then surged by 65.21% to -$395864.6 in 2024, then slumped by 1648.95% to -$6.9 million in 2025, then jumped by 95.72% to -$296057.5 in 2026.
- Per Business Quant, the three latest MCUJF Income towards Parent Company figures stand at -$296057.5 (Q1 2026), -$6.9 million (Q4 2025), and -$1.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.88 Bn | 32.14 Bn | 1.97 Bn |
| 3 | Zoetis | 32.64 Bn | 30.70 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.04 Bn | 20.88 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.37 Bn | 18.57 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.45 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -296,057.51 |
| Dec 31, 2025 | -6.92 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | -567,266.02 |
| Mar 31, 2025 | 430,694.38 |
| Dec 31, 2024 | -395,864.57 |
| Sep 30, 2024 | 498,476.32 |
| Jun 30, 2024 | -889,798.05 |
| Mar 31, 2024 | 37,847.77 |
| Dec 31, 2023 | -1.14 Mn |
| Sep 30, 2023 | 62,658.16 |
| Jun 30, 2023 | 188,346.47 |
| Mar 31, 2023 | 201,197.41 |
| Dec 31, 2022 | 3.97 Mn |
| Sep 30, 2022 | 1.89 Mn |
| Jun 30, 2022 | 568,646.97 |
| Mar 31, 2022 | 280,263.77 |
| Sep 30, 2021 | -2.04 Mn |
| Jun 30, 2021 | 407,577.11 |
| Mar 31, 2021 | 828,023.88 |